Clinical Trial

Observational Study of THC Concentrations in Acute Cannabis-induced CNS Depression

Recruiting
View on ClinicalTrials.gov →
Summary
This observational study is being conducted to determine plasma concentrations of tetrahydrocannabinol (THC) and its metabolites, 11-OH-THC and THC-COOH, in plasma of pediatric patients who visit the emergency department due to acute cannabis-induced CNS depression.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-08-24; most recent amendment 2026-02-13.
Status change: Active, Not Recruiting → Recruiting 2026-02-13
Status change: Recruiting → Active, Not Recruiting 2025-10-16
Trial Details
NCT Number NCT06017622
Lead Sponsor Anebulo Pharmaceuticals
Conditions Acute Cannabis-induced CNS Depression
Enrollment 36 participants
Start Date 2023-06-01
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-30